Although atrial fibrillation (AF) often exists in patients with hypertrophic obstructive cardiomyopathy (HOCM), combination of tricuspid regurgitation (TR) and AF after implantation of pacemaker/implantable cardioverter defibrillator (ICD) lead and its optimal management have not been well discussed in this population. Herein, we present a patient with HOCM who subsequently died due to severe heart failure and deterioration of TR following ICD lead placement with AF. Autopsy findings demonstrated that ICD leads were entrapped by anomaly structure in the right atrium and ventricle, which might affect deterioration of TR.
| CASE REPORT
A
| DISCUSSION
Although AF is well known as an independent predictor of poor outcomes in HOCM, this is the first report, which demonstrated how | 91 the atrial and ventricular leads in the RA. TR is rarely significant immediately after device-lead implantation, probably because the fibrous tissue formation due to the inflammatory change, which potentially limits its flexibility, starts at least weeks to months later. [3] [4] [5] In this patient, restriction of septal leaflet likely due to lead contact was evident by TEE late after ICD implantation. More frequent AF might dilate RA, which restricted septal leaflet more significantly by RV lead retraction. Although lead entrapment contributes to subsequent deterioration of TR, AF became more frequent after ICD implantation and also caused exacerbation of TR due to annular dilation, suggesting more aggressive treatment to AF might prevent or minimize her refractory heart failure. 1, 5 Subcutaneous ICD for avoiding passing through tricuspid valve may also be helpful in such patient.
The fibrous tissue between the tip of the ICD lead and the RA wall is consistent with further expansion of the RA and dilation of the tricuspid annulus after its implantation. On the other hand, the RV was not further dilated, which is consistent with unchanged pulmonary artery pressure, main contributor of tricuspid tethering.
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